Copy Number Profiling of Brazilian Astrocytomas
Author(s) -
Lucas Tadeu Bidinotto,
Raul Torrieri,
Alan Mackay,
Gisele Caravina de Almeida,
Marta VianaPereira,
Adriana CruvinelCarloni,
Maria Luisa Corcoll Spina,
Nathália C. Campanella,
Weder Pereira de Menezes,
Carlos Clara,
Aline Paixão Becker,
Chris Jones,
Rui Manuel Reis
Publication year - 2016
Publication title -
g3 genes genomes genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.468
H-Index - 66
ISSN - 2160-1836
DOI - 10.1534/g3.116.029884
Subject(s) - pdgfra , cdkn2a , idh1 , pten , microsatellite instability , glioma , in silico , biology , cancer research , anaplastic astrocytoma , carcinogenesis , astrocytoma , gene , mutation , genetics , microsatellite , allele , pi3k/akt/mtor pathway , apoptosis , gist , stromal cell
Copy number alterations (CNA) are one of the driving mechanisms of glioma tumorigenesis, and are currently used as important biomarkers in the routine setting. Therefore, we performed CNA profiling of 65 astrocytomas of distinct malignant grades (WHO grade I-IV) of Brazilian origin, using array-CGH and microsatellite instability analysis (MSI), and investigated their correlation with TERT and IDH1 mutational status and clinico-pathological features. Furthermore, in silico analysis using the Oncomine database was performed to validate our findings and extend the findings to gene expression level. We found that the number of genomic alterations increases in accordance with glioma grade. In glioblastomas (GBM), the most common alterations were gene amplifications (PDGFRA, KIT, KDR, EGFR, and MET) and deletions (CDKN2A and PTEN) Log-rank analysis correlated EGFR amplification and/or chr7 gain with better survival of the patients. MSI was observed in 11% of GBMs. A total of 69% of GBMs presented TERT mutation, whereas IDH1 mutation was most frequent in diffuse (85.7%) and anaplastic (100%) astrocytomas. The combination of 1p19q deletion and TERT and IDH1 mutational status separated tumor groups that showed distinct age of diagnosis and outcome. In silico validation pointed to less explored genes that may be worthy of future investigation, such as CDK2, DMRTA1, and MTAP Herein, using an extensive integrated analysis, we indicated potentially important genes, not extensively studied in gliomas, that could be further explored to assess their biological and clinical impact in astrocytomas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom